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Abstract Nephrotic syndrome (NS) is a clinical diagnosis
with proteinuria, hypoalbuminaemia and oedema. NS is
rare in children, and its incidence in The Netherlands is
unknown. The aim of this study was to estimate the
incidence of idiopathic NS in the Netherlands. All
paediatric patients (age 0–18 years) with a newly diagnosed
NS in the Netherlands were registered by the Dutch
Pediatric Surveillance Unit during the years 2003 until
2006, secondary NS was excluded. All paediatricians filled
out questionnaires about the first clinical findings of the
patients and incidences were calculated. A literature review
on incidences of childhood NS was conducted. The
incidence of NS in children in the Netherlands in the years
2003 until 2006 was 1.52/ 100, 000 children/ year. The
median age at diagnosis was 3.88 years with a mean age of
5.08 years. A significant male:female ratio of 2.04:1 was
found. This prospective study of NS in the Netherlands
revealed an incidence of 1.52:100, 000 children/year, and is
similar to the incidences found all over the world.
Keywords Children.Epidemiology.Incidence.Nephrotic
syndrome.Prospective study.Review of literature
Introduction
Nephrotic syndrome (NS) is the most common glomerular
disorder of childhood. It is defined by proteinuria,
hypoalbuminaemia, oedema and hyperlipidaemia [1]. Most
(80%) children have a minimal-change NS (MCNS). Other
diagnoses, which could be the cause of NS, are focal
segmental glomerulosclerosis (FSGS), congenital NS
(CNS) and NS due to glomerulonephritis or other glome-
rulopathies. Although NS is relatively rare, it accounts for
mortality and considerable morbidity in young children.
The prognosis of NS in children correlates with the
spectrum of responsiveness to steroid therapy, from
steroid-sensitive NS (SSNS) to steroid-resistant NS
(SRNS). SRNS is the most common acquired cause of
end-stage renal disease (ESRD) in children [2]. The aim of
this study was to determine the incidence of NS in The
Netherlands. All new cases of NS in The Netherlands of
children 0–18 years of age were prospectively registered
from 1 January 2003 till 1 January 2007. The second aim
was to compare these results with the incidences of NS
described in the literature.
Methods
Literature search
A literature search was done in February 2009. We
searched for articles in PubMed and Embase. Relevant
thesaurus terms and/or free-text terms for NS, epidemiol-
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used. The searches were limited to the age group of 0–
18 years and articles written in English, French, German,
Dutch or Arabic. Inclusion criteria were all studies on NS
that describe the incidence or epidemiology of NS in
children 0–18 years in a nationwide or a hospital
population.
Study design
The registry was started by the working group Idiopathic
Nephrotic Syndrome, which consists of all paediatric
nephrologists in The Netherlands in collaboration with the
Dutch Pediatric Surveillance Unit hosted by The Nether-
lands Institute of Applied Science [Nederlands Signalerings
Centrum Kindergeneeskunde (NSCK) at TNO, Leiden].
The NSCK is a voluntary national registry used by
paediatricians to report various rare or new paediatric
disorders and is one of 13 paediatric surveillance units in
the world. Our study includes all children with newly
diagnosed NS between 1 January 2003 and 1 January 2007.
The case definition was any child <18 years with symptoms
of NS defined as oedema, proteinuria (> 3 + on a dipstick),
low serum albumin (<25 g/l) and normal renal function
(serum creatinine in normal range for age when not volume
depleted), without signs of systemic disease or macroscopic
haematuria. The study was conducted in The Netherlands.
All paediatricians in The Netherlands received a monthly
blue card or Web link to an electronic card and were asked
to return the card to the NSCK if they had a patient with a
newly diagnosed NS. A questionnaire was sent to the
registering paediatrician, which had to be returned to the
Idiopathic Nephrotic Syndrome Working Group at the VU
University Medical Center, where data were analyzed.
When the questionnaires were incomplete, secondary phone
calls and visits were carried out to try to complete them as
far as possible. The coded questionnaires showed only
initials, birth date and a part of the postal code. Medical
ethical approval was thought not to be necessary due to the
anonymous submission of the questionnaires. Informed
consent forms were filled in by the parents of the patients.
The number of responding paediatricians working in The
Netherlands in 2003–2006 was 694 (mean) divided over 96
paediatric practices and eight university centres with a
paediatric nephrology department.
Statistical analysis
The incidence of NS was calculated by relating the number
of de novo NS patients to the number of children <18 years
who were living during the 4 years of registration in the
several provinces separately and in The Netherlands as a
whole. The population numbers were extracted from the
official statistics organ (Statistics Netherlands). These data
can be found on the Web site and are freely available. Male:
female ratio and median and mean age of the affected
children were calculated from the available data. Pearson’s
chi-square test was used to compare the incidences of the
years and the provinces. A p value <0.05 was considered to
be significant.
Results
Literature review
We found 504 abstracts from PubMed and 214 abstracts
from Embase; 669 abstracts were left after removing
duplicates. Thirty-one appeared to fulfil the inclusion
criteria, but after reading the full articles, only nine fulfilled
all inclusion criteria. We found three more abstracts
(personal enquiry) that were not found in the systematic
search. Hodson et al. [3] published the results of a national
registry of children with NS in Australia in the annual
report of the Australian Paediatric Surveillance Unit, and
Bouissou et al. presented a poster about the epidemiology
of NS in two French regions at the European Society of
Paediatric Nephrology Congress of 1993. Ultimately, nine
retrospective and three prospective studies met all inclusion
criteria (Table 1).
Registry
Between January 2003 and December 2006, 300 children
were reported. Initially, the response rate of NSCK was
92.8% (mean of the years 2003–2006) [4], but after first
and second reminders and active inquiries, the response rate
increased to 96.7%. Of the 300 questionnaires, 69 did not
meet the inclusion criteria due to the fact that some patients
did not have a newly diagnosed NS during the period of
registration (7.3%) but had a relapse, and other patients
were registered as NS but had another illness (6.0%). There
were 4.3% duplicate questionnaires. Seven patients (2.3%)
were diagnosed abroad with NS: six in The Netherlands
Antilles (one on Saint Martin and five on Curaçao), and
another in India (this child was later adopted to The
Netherlands). These patients were not included in the Dutch
incidence for that particular year. During the period of
enquiry, five (1.7%) medical charts could not be found.
Finally, four patients (1.3%) with CNS were excluded.
Ultimately, 231 patients (77.0%) met the inclusion criteria.
The calculated annual incidence of NS in The Nether-
lands in 2003–2006 was 1.52 per 100,000 living children
per year. The incidence for each year ranged from 1.32 to
1.77 per 100,000 children per year. The annual incidences
did not differ significantly. The distribution of patients in
1242 Pediatr Nephrol (2011) 26:1241–1246The Netherlands with its 12 provinces is shown in Fig. 1.
This is a chart of the place of residence of all registered
patients. There was no statistically significant difference in
distrubution within the provinces. This was also corrected
for population density in each province.
The Dutch cohort counted 76 girls and 155 boys with
newly diagnosed NS. There was a significant difference
between the numbers of boys versus girls (p=0.0005).
Median age was 3.88 years at admission (mean 5.08 years).
One child was younger than 12 months and older than 3
months. One patient died within a few weeks after
diagnosis as a result of sepsis and disseminated intra-
vascular coagulation. The mortality rate was 1 of 231
patients (0.43%) during the first 5 weeks after presentation.
Table 1 Results of the literature review on incidences of neprhrotic syndrome (NS) in childhood
Source Study period Country (area) Number of
patients
Male:female Age Incidence
(per 100,000/year)
Retrospective studies
Elzouki et al. [5] 1968-1982 Benghazi, Libya 134 1.3:1 12 weeks-14 years 11.6
Mean 5.7 (1.5-13)
Feehally et al. [6] 1973-1982 Leicestershire, UK 43 Asian 2.0:1 < 15 years 2.3
Mean age
Non-Asian 1.4:1 Asian 4,2 Asians 9.4
N-Asian 4.3 Non-Asians 1.3
McKinney et al. [7] 1 Jan 1987–31
Dec 1998
Former Yorkshire
Regional Health
Authority, UK
194 1.6:1 0-15 years 2.3
Median SSNS 4.5
SRNS 6
Schlesinger et al. [8] 1946- 1961 Erie county, USA 86 1.96:1 < 16 years 2.0
Sharples et al. [9] 1 Jan 1979– 31
Dec 1983
Birmingham, UK 44 1.8:1 < 16 years 5.3
Mean age Asian 16.9
Asian 3.4 European 2.6
European 4.2 Afro-Caribbean 3.4
Srivastata et al. [10] 1984-1995 Metropolitan area of
Kansas City, USA
Group A 148 Group A 1.5:1 1-16 years Group B primary
NS 2.2 Group A mean 6.6
Median 5.0 Caucasian 1.8
Group B 86 Group B 1.46:1 Group B African American
3.6 Mean 7.38
Median 5.0
Wyatt et al. [11] 1970-1979 Eastern part of
Kentucky, USA
34 2.09:1 1-10 years 1.8
Zaki et al. [12] 1981-1985 Farwaniya and Jahra,
Kuwait
55 1.75:1 < 12 years 7.2 (< 10 years)
Mean age 5.3 6.0 (< 12 years)
Rothenberg et al. [13] 1949-1953 Cleveland, Ohio, USA Ohio 172 1.07:1 0-9 years Ohio 2.3
Greater
Cleveland 54
Greater Cleveland
6.9
Prospective studies
Wong et al. [14] 1 Jul 2001–1
Jul 2004
New Zealand 49 2.5:1 3 months- 15 years 1.9
Mean 6.1
Median 4.9
Hodson et al. [3] Jul 1998-
Dec 2000
Australia 135 1.21: 1 3 months −15 years 1.15
Bouissou et al.
(ESPN 1993)
1985-1992 Midi-Pyrenees and
Auvergne, France
NA 1.57:1 1-15 years 2.1
El Bakkali et al.
(this study)
2003-2006 The Netherlands 231 2.04:1 0-18 years 1.52
Median 3.88
Mean 5.08
SSNS steroid-sensitive NS, SRNS steroid-resistant NS, NA not available, ESPN European Society of Paediatric Nephrology
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The articles found in the literature review relate mostly to
retrospective studies from around the world (Table 1). They
describe different populations, backgrounds and a large
variability in genetics. All these factors influence the
comparability.
Historic retrospective study dates are reported from 1946
onwards (Erie County, OH, USA) till 1998 (Yorkshire, UK)
[5–13]. From the three prospective studies, one was from
France (1985–1992) (Bouissou et al. ESPN 1993) and the
other two from New Zealand and Australia in 1998–2004
(Table 1)[ 3, 14]. The retrospective articles merely studied a
hospital population or part of the population in a city,
region, county or several districts. Thus, results from a wide
variety of populations make them difficult to compare. A
retrospective incidence in different age groups was reported
as 1.8–11.6:100,000 patients/year [5–13]. The two more
recent prospective population studies in New Zealand and
Australia were quite similar to the one in The Netherlands,
and they also used the Paediatric Surveillance Unit to
register all new cases of NS [3, 14]. To our knowledge, the
Dutch study is the largest and longest prospective study so
far.
We registered all children with NS in The Netherlands
for 4 years. The NSCK shows a response rate of 92.75%
[4]. Beyond that, we extensively explored possible non-
registered cases by regular announcements, personal tele-
phone calls and e-mail contacts with nearly all Dutch
paediatricians. We believe that we have registered all
children with newly diagnosed NS in The Netherlands, so
defining a reliable incidence. The three prospective studies
revealed an incidence of 1.15–2.1 per 100,000 [3, 14]
children per year, which was comparable with the Dutch
incidence of 1.52 per 100,000 children per year in 2003–
2006. In contrast to the studies in Australia [3] and France
(Bouissou et al, ESPN 1993), our Dutch population showed
a higher male preponderance, whereas the study in New
Zealand [13] showed an even higher male:female ratio
(2.5:1). In comparison with the retrospective studies the
Fig. 1 Distribution of patients
with a newly diagnosed
nephrotic syndrome in The
Netherlands during 2003–2006
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the study by Schlesinger et al. in Erie County, OH, [8] and
Wyatt et al. in the eastern part of Kentucky in the United
States [11]. The other studies show a lower male:female
ratio [5–7, 9, 10, 12, 13]. Even if the older children
(>15 years) were left out, compared with the registration in
Australia [14], this predominance still existed. In the
general population in The Netherlands, the male:female
ratio is 1.05:1, and in Australia this ratio is also 1.05:1;
thus, this does not explain the difference between the two
countries. Wong et al. do not explain why they think that
the ratio found in their study differs from the rest of the
studies [14]. We do not have a thorough explanation for the
difference in male:female ratio between the studies. Boyer
et al. [15] described that patients with FSGS were older at
diagnosis and that the female gender was slightly over-
represented in comparison with children with another
aetiology of NS. In our study, the male predominance was
present in nearly all age groups.
The definition of NS was similar in all studies in relation
to symptoms and laboratory findings. However, the
inclusion criteria of ethnic background and age were not
comparable. Our registry included all children aged from 0
to 18 years. After we completed the database, children with
congenital NS were excluded because of the difference in
pathogenesis. During the 4 years of registration, four
children with congenital NS were excluded. According to
this registration, the incidence of CNS in The Netherlands
was one child with CNS per year. Exclusion of CNS is the
reason that some studies started registration from 3 months
onwards.
Wong et al. [13], Srivastata et al. [10] and McKinney et
al. [7] reported a median age of, respectively, 4.5, 5.0, 4.5
(SSNS) and 6.0 (SRNS) years; mean age differed from 3.4
to 7.4 years [7, 10, 13]. Some studies did not mention a
median or mean age. The median age found in our study
was 3.9 years and is lower than the ones found in the
reviewed literature, where mean age appeared to be
5.1 years. Due to the fact that some ethnic groups seem to
be more prone to developing FSGS (e.g. African American
and Indian children) rather than MCNS [16], retrospective
studies might be biased, because they are mostly based on
medical charts in one centre or region of a country. In our
prospective study, a question about the ethnic background
was not included. Ethnicity will be explored in a follow-up
study planned to begin soon. Some paediatricians sponta-
neously mentioned the ethnicity of their patient in the
questionnaire. For 32 patients, ethnicity is not known
(14%). With the gathered information in the questionnaires
so far and the informed consent forms, we were able to
divide the rest of the patients into Western and non-Western
ethnic group. The majority of patients (60.1%) were of
Dutch nationality (from western origin). The non-Western
patients (25.9%) came from a wide variety of countries
divided over all continents.
The mortality rate in this study is preliminary because it
only shows the number of patients who died at presenta-
tion. To our knowledge, other series do not report mortality
at presentation. This means that NS is still a serious disease,
even at presentation. Two other authors published mortality
rates, but all in earlier years, and were not comparable with
idiopathic NS as stated in the definition [8, 13].
In conclusion, our study showed an incidence in the
same range as the few other prospective studies. Idiopathic
NS in children in the Dutch population is as much a rare
disease as in any other country in the world. We found a
statistically significant male:female ratio in this study,
which is not fully explained but is in line with one other
prospective study that described a similar or even higher
male:female ratio in their cohort. Given the rarity of the
disease and the lack of understanding of the exact patho-
genesis of NS in children, more research is needed,
preferably done in international collaboration studies.
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